Any consideration of GLP-1 therapy should involve comprehensive evaluation by an endocrinologist or appropriate specialist, with clear discussion of the investigational nature of this approach, potential risks, costs, and the importance of ongoing monitoring
Beyond their well-established benefits in managing type 2 diabetes mellitus (T2DM) and promoting weight reduction, emerging evidence suggests that GLP-1 RAs may also offer neuroprotective, anti-inflammatory, and cardiovascular protective effects 4,5,6,7
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: Implications for Parkinsons disease
Legal action against Novo Nordisk may achieve justice and compensation for affected people
Patisiran: first global approval
You can manage nausea by eating bland, low-fat foods like crackers and toast